Your Article Summary
Human genome sciences to host july conference call to discuss top-line phase 3 results for benlysta (formerly lymphostat-b) in systemic lupus erythematosus
Human Genome Sciences, 07/02/09
Human Genome Sciences, Inc. announced that it expects to have top-line results available on Monday, July 20, from BLISS-52, the first of two pivotal Phase 3 clinical trials of BENLYSTA in systemic lupus erythematosus (SLE).
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
Quality of trials reported as conference abstracts in China: How well are they reported
International Journal of Technology Assessment in Health Care, 11/05/09
User Groups Prove Helpful
HealthDataManagement, 11/03/09
Salix Pharmaceuticals Reviews American Association For The Study Of Liver Diseases Annual Meeting
Salix Pharmaceuticals, 11/03/09
Article Search
Sponsor


See Latest Articles


